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Background: This study investigated the effects that hair dye use and regular exercise exert on the risk and
prognosis of prostate cancer.
Methods: We studied 296 cases of histologically confirmed prostate cancer and 296 age- (in 2-y bands), ethnicity-,
and hospital-matched controls in Taiwan between August 2000 and December 2008. To determine the rate
of prostate cancer survival, another 608 incident prostate cancer cases occurring between August 2000 and
December 2007 were investigated. Information on hair dye use and regular exercise was obtained using a
standardized questionnaire.
Results: The use of hair dyes was associated with a significant 2.15-fold odds of developing prostate cancer
(adjusted odds ratio = 2.15, 95 % confidence interval [CI] = 1.32–3.57), but was not associated with prostate
cancer survival, compared with no use. The significant risks were more prominent in users aged < 60 years who had
used hair dyes for > 10 years, > 6 times per year, and started using hair dyes before 1980. By contrast, regular exercise
significantly reduced the number of prostate-cancer-specific death (adjusted hazard ratio = 0.37, 95 % CI = 0.16–0.83);
the protective effect of exercise was more prominent among cancer patients who exercised daily (≥7 times/week).
However, exercise could not prevent the development of prostate cancer.
Conclusions: Hair dye use increased the risk of prostate cancer, whereas regular exercise reduced the number of
prostate-cancer-specific deaths.
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Prostate cancer is the most frequently diagnosed cancer,
second only to skin cancer, and the second-leading cause
of cancer death in the United States; it is estimated to
have caused 27,050 deaths in 2007 [1]. Although the in-
cidence rate of prostate cancer was reported to be lower
among Asian populations than among Caucasian popu-
lations, the annual incidence rate of prostate cancer in* Correspondence: shpihu@yahoo.com.tw; 960021@ms.kmuh.org.tw
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people in 1995 to 12.1 per 105 people in 2007 [2]. Vari-
ous etiologic studies have suggested that the strongest
risk factors for prostate cancer comprise older age, a
family history of the disease, and African American
ethnicity [3, 4]; however, numerous genetic and environ-
mental risk factors remain undetermined.
Accumulated evidence has indicated that 80 to 90 % of
human cancers might be attributable to environmental
and lifestyle factors such as dietary or cosmetic habits,
physical activities, and substance use [5–7]. Among
these factors, hair dye use and regular exercise are 2
common practices in daily life [8, 9].istributed under the terms of the Creative Commons Attribution 4.0
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market of approximately US$12 billion per year world-
wide, and as much as 50 % of the adult population in
developed countries has used hair colorants [9]. Hair
coloring products include a wide range of more than
5,000 chemical substances, some of which have been
reported to be mutagenic and carcinogenic according to
various bioassay results [10]. Numerous oxidative dyes
were reformulated in the early 1980s to eliminate ingre-
dients that induced tumors; however, whether current
compounds exert carcinogenic effects or affect overall
immune responses remains unclear [11, 12]. Relevant
studies have reported scant evidence regarding the asso-
ciation between hair dye use and cancer risk, except for
a possible cause of hematopoietic cancers [13–18] and
bladder cancer [11, 15, 19–23]. No epidemiologic studies
have investigated the relationship between hair dye use
and the risk and prognosis of other genitourinary tract
cancers such as prostate cancer.
Numerous studies have examined whether increased
physical activity can reduce the risk of prostate cancer
[24–30]; the conclusion remains conflicting, although
most studies have reported no association between them
[24, 26, 28–30]. Moreover, few studies have examined
whether physical activity can improve the prognosis of
prostate cancer. Thus, in this study, we attempted to
clarify the relationships among hair dye use, regular
exercise, and the risk and prognosis of prostate cancer.
We hypothesized that increased hair dye use and
decreased regular exercise would increase the risk of




To investigate the risk of prostate cancer, we conducted
a hospital-based case–control study at 2 large medical
centers: Kaohsiung Medical University Hospital (KMUH)
and Kaohsiung Veterans General Hospital (KVGH),
located in Southern Taiwan. Case patients comprised men
who had been newly diagnosed with and pathologically
proven to have adenocarcinoma of the prostate between
August 2000 and December 2008. We matched each case
patient with one healthy man (control) who received a
health check-up in the Department of Preventive Medi-
cine during the same month that the case patient was
diagnosed; the patients and controls were frequency
matched according to age (in 2-y bands), ethnicity, and
hospital of origin. The controls had undergone digital rec-
tal examinations, the results of which were normal, and
had serum prostate-specific antigen (PSA) levels lower
than 4 ng/dL.
To investigate the survival rate of patients with pros-
tate cancer, we conducted a case-only study, recruitingpatients newly diagnosed with adenocarcinoma of the
prostate at the Third Medical Center at National Taiwan
University Hospital (NTUH) in Northern Taiwan be-
tween August 2000 and December 2007. Because the
National Death Registry of Taiwan has released the per-
sonal information, health status, and cause of death for
patients diagnosed before December 2007, we studied
only the cases of patients who were diagnosed before
December 2007 in this case-only study. The 3 hospitals
are the main medical centers in their geographic areas
and are accessible to patients from all socioeconomic
groups in Taiwan.
Data collection
Participants in the case–control and case-only studies
underwent in-person interviews conducted by trained
interviewers using standardized questionnaires. The in-
terviewers questioned the paired case patients and the
controls regarding demographic and lifestyle characteris-
tics before they were diagnosed with prostate cancer.
The questionnaire included questions pertaining to the
demographic characteristics of age, body height and
weight (used to calculate body mass index [BMI]), edu-
cation attainment, marital status, blood type, vasectomy
history, and family history of cancer. In addition to the
studied exposure factors (hair dye use and regular exer-
cise), we collected other common and relevant environ-
mental and lifestyle factors, such as diet and habitual
substance use, including cigarette smoking, alcohol con-
sumption, and betel nut chewing.
Cigarette smokers, alcohol drinkers, and betel nut
chewers were separately defined as participants who had
smoked 10 cigarettes per week for a minimum of
6 months; or consumed any alcoholic beverage once per
week for a minimum of 6 months; or chewed one betel
nut quid per day for a minimum of 6 months, respect-
ively. The age at which substance use began and ceased,
the type of substance, and the daily consumption
amount and duration of use were documented for iden-
tified substance users [31]. The accuracy of information
pertaining to substance use that was obtained from the
questionnaires has been validated in our previous studies
on esophageal cancer [32–34].
Assessment of hair dye use and exercise status
Hair dye habit was defined as dyeing the hair a minimum
of once every 3 months for at least 1 year. Detailed infor-
mation regarding the age at first and final use, frequency,
and years of use were recorded for identified hair dye
users. Regular exercise habits were assessed by asking par-
ticipants whether they exercised aerobically for a mini-
mum of 20 min and perspired, performing this activity
regularly for at least 1 year. If participants had regular
exercise habits, we asked them to report their average
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4–6 times/week; 1–3 times/week; 1–4 times/month;
and < 1 time/month).
Clinical characteristics
The clinical-pathological characteristics, including the
Gleason score, stage of disease, and serum PSA level at
diagnosis, were obtained from chart review and are de-
scribed in detail elsewhere [35, 36]. Disease stage was
determined by analyzing the pathological findings, pelvic
computed tomography or magnetic resonance imaging,
and radionucleotide bone scans, according to the criteria
established by the American Joint Committee on Cancer
(AJCC) tumor, node, and metastasis classification system
(AJCC Cancer Staging Manual, Fifth Edition, 1997). The
pathologic grade was determined according to Gleason
scores and was classified into 3 groups (≤6, 7, or 8–10)
[37]. Information on death from any cause was obtained
from the National Death Registry of Taiwan, which is
accurate and complete because death registration is
mandatory in Taiwan and physicians must issue death
certificates [38]. This study was approved by the Institu-
tional Review Board of the Kaohsiung Medical University
Chung-Ho Memorial Hospital, Kaohsiung Veterans
General Hospital, and the Research Ethics Committee of
National Taiwan University Hospital. The written in-
formed consent was obtained from all the study partici-
pants of the 3 medical centers prior to participation.
Statistical analysis
Demographic and clinical characteristics were tabulated
for the cases and controls in the case–control study.
Multivariable unconditional logistic regression models
were used to estimate the odds ratios (ORs) and 95 %
confidence intervals (CIs) for the relationships among
hair dye use, regular exercise, and the risk of prostate
cancer after adjustment for other covariates. Initially, we
included the variables that have been considered signifi-
cant risk factors or protective factors for prostate cancer
in previous studies, including age (>65 y, ≤ 65 y), educa-
tion attainment (< high school, high school, > high
school), and family history of prostate cancer (yes, no).
Missing data were classified into an additional category
in the models to maximize the study participants. The
additional variables were then added to the models ac-
cording to forward stepwise selection, and were included
in the models if they caused a minimal 10 % change in the
association between hair dye use or regular exercise and
prostate cancer risk for the risk of or protection against
prostate cancer. The selected variables included marital
status, BMI (<24 kg/m2, 24–26 kg/m2, ≥ 27 kg/m2),
cigarette smoking (yes, no), alcohol consumption (yes,
no), betel nut chewing (yes, no), blood type, vasectomy
history, and food or nutrient intake (multivitaminsupplements, tea, coffee, milk, soy products, and instant
noodles). Because the intake frequency of specific nutri-
tional supplements—including vitamins A, B, C, D, and E,
and calcium—was less than 5 % among the study partici-
pants, we merged them into the multivitamin supplement
category. The covariates used in the final model of the
case–control study comprised age, marital status, blood
type, education attainment, family history of prostate can-
cer, cigarette smoking, alcohol consumption, and betel nut
chewing. We used an additional model, which only ad-
justed with age and family history of prostate cancer that
is the risk factors for prostate cancer with sufficient
evidence as race.
In addition to analyzing whether participants used hair
dyes (yes, no), we categorized hair dye use based on age
at first use (<50 y, 50–60 y, or ≥ 60 y), duration of use
(≤10 y and > 10 y), frequency of use (<6 times/y and > 6
times/y), and year of first use (before and after 1980,
which is the approximate year of the reformulation of
dye products). We categorized exercise by frequency
(1–6 times/week and ≥ 7 times/week).
For the case-only study, Kaplan–Meier analysis and
log-rank testing were used to examine the relationship
between personal hair dye use or regular exercise and
the prostate cancer patient survival rate. Cox propor-
tional hazards modeling was employed to compute haz-
ard ratios (HRs) and 95 % CIs for prostate cancer deaths
after adjustment for other covariates. The covariates in-
cluded in the model were the clinical stage, PSA level,
and the same covariates used in the case–control study.
Each participant accumulated person-time beginning
from the prostate cancer diagnostic date and ending on
the date of prostate-cancer-related death or the end of
this study in December 2007. If patients died from other
causes, they were censored to account for the competing
death attributable to other causes [39]. In addition, we
analyzed the effect that exposure (hair dye use or regular
exercise) exerted on the death attributable to other
causes by censoring the study participants with
prostate-cancer-specific deaths. Data analysis was per-
formed using the SAS 9.1 statistical package; all P values
were 2-sided and significant below the .05 level.
Sensitivity analysis
Sensitivity analyses were conducted in both the case–
control study and case-only study. In the matched
case–control study, we excluded the case patients
with a hair dye exposure history of less than 5 years
before the occurrence of prostate cancer to account
for a latent period, and examined the robustness of
ORs for hair dye use. Because we did not inquire
about the beginning or cessation of regular exercise
among the study participants, we could not analyze
how this variable affected the risk of prostate cancer.
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who were recruited before December 2006. For the
missing data, in addition to treating them as an add-
itional category, we also analyzed the participants
without missing data [40].Results
Between August 2000 and December 2008, 394 partici-
pants, aged 50 to 90 years, were pathologically diagnosed
with prostate cancer. After excluding cases in which
patients were diagnosed with other cancers (N = 13) or
that had no available matching control (N = 85), we ob-
tained 296 cases and 296 controls for the final statistical
analysis (Fig. 1). The numbers of patients who dyed their
hair and exercised were 95 (32.1 %) and 174 (58.8 %) in
296 cancer patients, and 28 (28.6 %) and 49 (50.0 %) in
98 excluded cancer patients. No significant differences
in exposure distributions were observed between in-
cluded and excluded cancer patients (χ2 = 0.426 and
2.313; P = .514 and .128). For the survival analysis, 608Fig. 1 Study flowchartpathologically diagnosed prostate cancer patients (227
from KMUH and KVGH, and 381 from NTUH) were
analyzed.
Table 1 lists the main demographic and clinical char-
acteristics for the case–control and case-only studies
(Additional file 1: Table S1 for other variables). In the
case–control study, the average age and BMI of the
study population were 71.6 years and 24.3 kg/m2, re-
spectively. Except for the variables of marital status and
blood type, the frequency of other variables was non-
significant between cases and controls (Table 1 and
Additional file 1: Table S1).
The use of hair dye was more prevalent among case
patients than controls (32.1 % vs 21.6 %; Table 2). After
adjustment for other covariates, the development of
prostate cancer in hair dye users was 2.15-fold higher
(95 % CI = 1.32–3.57) than that in nonusers. Among the
users, the average (± SD) number of years of hair dye
use was 13.9 ± 10.9, ranging from 1 to 50 years. The
significant risks were more prominent in the users
aged < 60 years who had used hair dyes for > 10 years
Table 1 Demographic and clinical characteristics of the 296 matched case–control study and the 608 case-only study
Cases Controls All cases
Variables N = 296 N = 296 P-value N = 608
N (%) N (%) N (%) Deatha (N = 48)
Study site1
South 296 (100.0) 296 (100.0) 227 (37.3) 19
North - - 381 (62.7) 29
Age (yrs)
Mean ± SD 71.3 ± 7.4 70.9 ± 8.0 0.622 71.6 ± 8.6
<65 58 (19.6) 64 (21.6) 0.430 133 (21.9) 8
≥65 229 (77.4) 215 (72.6) 471 (77.5) 40
Missing 9 17 4
BMI (kg/m2)
Mean ± SD 24.2 ± 3.1 24.1 ± 3.2 0.742 24.3 ± 3.2
<24 130 (43.9) 134 (45.3) 0.967 277 (45.6) 27
24– < 27 90 (30.4) 89 (30.1) 207 (34.0) 13
≥27 41 (13.9) 43 (14.5) 98 (16.1) 5
Missing 35 30 26 3
Education
<high school 100 (33.8) 111 (37.5) 0.861 175 (27.8) 18
High school 85 (28.7) 86 (29.1) 225 (37.0) 17
>high school 66 (22.3) 66 (22.3) 178 (29.3) 13
Missing 45 33 30 0
Marital status*
Single/widowed/separated/divorced 44 (14.9) 30 (10.1) 0.047* 55 (9.0) 6
Married 205 (69.3) 231 (78.0) 520 (85.5) 42
Missing 47 35 33
Vasectomy
No 215 (72.6) 199 (67.2) 0.628 516 (84.9) 39
Yes 10 (3.4) 7 (2.4) 17 (2.8) 0
Missing 71 90 75 9
Family history of PC
No 226 (76.4) 245 (82.8) 0.243 523 (86.0) 43
Yes 17 (5.7) 11 (3.7) 32 (5.3) 3
Missing 53 40 53
Cigarette Smoking
No 153 (51.7) 159 (53.7) 0.561 293 (48.2) 20
Yes 143 (48.3) 135 (45.6) 315 (51.8) 28
Missing 0 2 0 0
Alcohol drinking
No 199 (67.2) 208 (70.2) 0.459 428 (70.4) 28
Yes 95 (32.1) 87 (29.4) 179 (29.4) 20
Missing 2 1 1 0
Betel nut chewing
No 281 (94.9) 281 (94.9) 0.845 578 (95.1) 44
Yes 13 (4.4) 12 (4.1) 28 (4.6) 3
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Missing 2 3 2 1
Clinical stageb
Localized 290 (47.7) 7
Locally advanced 158 (26.0) 7
Bone metastasis 154 (25.3) 34
Missing 6 0
Gleason score
<6 255 (41.9) 11
7 191 (31.4) 12
8-10 154 (25.3) 25
Missing 8 0
Preoperative PSA (ng/ml)
<10 152 (25.0) 5
10- < 20 143 (23.5) 4
≥20 295 (48.5) 38
Missing 18 1
Abbreviation: BMI body mass index, PC: prostate cancer, PSA prostate-specific antigen
1Study site: North National Taiwan University Hospital, South: Kaohsiung Medical University Hospital and Kaohsiung Veterans General Hospital
*P-value < 0.05; aprostate cancer specific death; bTumor, node, metastasis system staging by American Joint Committee on Cancer (1997): Localized,
T1/T2 N0 M0; Locally advanced, T3/T4 N1 M0; Bone Metastasis, M1
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before 1980. By contrast, no protective effect was ob-
served for participants who exercised regularly (Table 2).
Although we restricted our analyses to participants with-
out missing data, the results remained similar (Additional
file 1: Table S2).
Among the 608 pathologically proven prostate cancer
patients, 99 died during the study period; among them,
48 (48.5 %) died from prostate cancer and 51 (51.5 %)
died from other diseases (Table 1). The mean and
median follow-up times were 25.7 and 22.2 months,
respectively, (range, 0.1–84.4 months). The use of hair
dye was not correlated with the clinical stage of prostate
cancer (categorized by localized, locally advanced, and
bone metastasis), whereas regular exercise was highly
correlated with the clinical stage (Additional file 1:
Table S3). In addition, the Gleason score and preopera-
tive PSA were significantly and positively associated with
the clinical stage after demographic characteristics were
adjusted for (Additional file 1: Table S3).
Cumulative incidence estimates of prostate-cancer-
specific deaths were statistically dissimilar between pa-
tients who exercised and those who did not (P < .001;
Fig. 2a). No significant relationship was present among
other causes of death (P = .278). The use of hair dye
did not affect cumulative incidence estimates of
prostate-cancer-specific deaths or deaths from other
causes (P = .753 and .693; Fig. 2b).
Regular exercise caused a 63 % decrease in the risk
of prostate-cancer-specific death (adjusted HR = 0.37;95 % CI = 0.16–0.83) after other covariates were ad-
justed for (Table 3). A significantly protective effect
was prominent among cancer patients who exercised
daily (≥7 times/week). By contrast, no significance
was observed for the use of hair dye (Table 3). As
expected, bone metastasis was the most crucial pre-
dictor of prostate-cancer-specific death (Additional
file 1: Figure S1; Table 3). To avoid “reverse causal-
ity,” we dichotomized the cancer patients into 2
groups based on the absence or presence of bone me-
tastasis. We found that the protective effect of regular
exercise on the prognosis of prostate-cancer-specific
deaths was significant in the group of bone metastasis
patients, but not in the group of non-bone metastasis
patients (Additional file 1: Tables S4 and S5).
Regarding deaths from other causes, regular exercise
exerted a protective but non-significant effect (adjusted
HR = 0.52; 95 % CI = 0.19–1.39; Additional file 1:
Table S4). Neither hair dye use nor the clinical stage
was significantly associated with deaths from other causes
after other covariates were adjusted for (Additional file 1:
Table S6).
Regarding the sensitivity analysis performed in the
case–control study, because all participants were diag-
nosed with prostate cancer after at least 5 years of
hair dye exposure, the results were unchanged. In the
case-only study, we restricted the analysis to case
patients (N = 445) who were recruited before December
2006, thus determining that the results were similar
(Additional file 1: Table S7).
Table 2 Odds ratio (OR) for cases and controls according to hair dyes use and regular exercise
Cases Controls Crude OR (95 % CI) AOR (95 % CI)a AOR (95 % CI)b
Variables N = 296 N = 296
N (%) N (%)
Hair dyes
No 197 (66.6) 231 (78.0) 1.00 1.00 1.00
Yes 95 (32.1) 64 (21.6) 1.74 (1.21–2.53)* 1.86 (1.21–2.82)* 2.15 (1.32–3.57)*
Missing 4 1 4.69 (0.69–92.10) 5.03 (0.73–98.83) 5.40 (0.76–108.02)
Age of first use (yrs)
Never 197 (66.6) 231 (78.0) 1.00 1.00 1.00
≥60 24 (8.1) 21 (7.1) 1.34 (0.72–2.49) 1.23 (0.63–2.39) 1.52 (0.71–3.30)
50- < 60 28 (9.5) 21 (7.1) 1.56 (0.86–2.87)* 2.19 (1.08–4.60)* 2.64 (1.16–6.36)*
<50 29 (9.8) 16 (5.4) 2.13 (1.14–4.11)* 2.32 (1.21–4.61)* 2.25 (1.01–5.19)*
Missing 18 7 3.02 (1.28–7.89) 2.70 (1.04–7.86) 4.29 (1.32–16.72)
P for trend <0.01 <0.01 <0.01
Years of use (years)
Never 197 (66.6) 231 (78.0) 1.00 1.00 1.00
≤10 40 (13.5) 35 (11.8) 1.34 (0.82–2.20) 1.49 (0.87–2.59) 1.57 (0.82–3.03)
>10 37 (12.5) 22 (7.4) 1.97 (1.13–3.50)* 2.10 (1.15–3.92)* 2.54 (1.23–5.41)*
Missing 22 8 3.22 (1.46–7.87) 3.23 (1.36–8.52) 5.43 (1.82–20.13)
P for trend 0.02 <0.01 <0.01
Frequency of use
(times per year)
Never 197 (66.6) 231 (78.0) 1.00 1.00 1.00
≤6 41 (13.9) 32 (10.8) 1.50 (0.91–2.49) 1.64 (0.95–2.85) 1.73 (0.91–3.32)
>6 35 (11.8) 25 (8.4) 1.64 (0.95–2.86) 1.97 (1.07–3.69)* 2.65 (1.26–5.78)*
Missing 23 8 3.37 (1.53–8.19) 2.82 (1.23–7.08) 3.85 (1.41–11.74)
P for trend 0.02 <0.01 <0.01
Year of first use
No 197 (66.6) 231 (78.0) 1.00 1.00 1.00
After 1980 5 (1.7) 3 (1.0) 1.95 (0.47–9.62) 1.25 (0.23–6.83) 0.89 (0.11–5.90)
Before 1980 76 (25.7 55 (18.6) 1.62 (1.09–2.41)* 1.87 (1.21–2.90)* 2.16 (1.28–3.68)*
Missing 18 7 3.02 (1.28–7.89) 2.71 (1.04–7.89) 4.32 (1.33–16.87)
Regular exercise
No 126 (42.6) 120 (40.5) 1.00 1.00 1.00
Yes 166 (56.1) 168 (56.8) 0.93 (0.67–1.28) 0.99 (0.69–1.43) 1.01 (0.64–1.59)
Missing 4 8 0.48 (0.02–5.03) none 1.03 (0.66–1.62)
Frequency of exercise
(times per week)
No 126 (42.6) 120 (40.5) 1.00 1.00 1.00
1-6 56 (18.9) 65 (22.0) 1.22 (0.79–1.89) 0.94 (0.58–1.53) 1.01 (0.55–1.86)
≥7 110 (37.2) 103 (34.8) 0.98 (0.68–1.42) 1.02 (0.68–1.54) 0.97 (0.58–1.62)
Missing 4 8 0.48 (0.12–1.55) 1.57 (0.25–12.15) 0.97 (0.11–8.50)
Abbreviation: AOR: adjusted OR; OR: odds ratio; PC: prostate cancer
aAdjusting for age, and family history of PC, bAdjusting for age, marital status, blood type, education, family history of PC, cigarette smoking, alcohol drinking and
betel nut chewing
*P-value < 0.05
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Fig. 2 Cumulative incidence estimates of prostate-cancer specific death and other-cause death categorized by regular exercise or hair dye use:
a by regular exercise; b by hair dye use
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Table 3 Prostate-cancer-specific death according to hair dye use and regular exercise in a Cox regression model
N Total 608 Prostate-cancer-specific death 48 HR (95 % CI) AHRa (95 % CI)
Variables N (%) N
Hair dyes
No 443 (72.9) 35 1.00 1.00
Yes 161 (54.4) 13 0.89 (0.45-1.65) 1.14 (0.47-2.59)
Missing 4 0
Years of use
Never 443 (72.9) 35 1.00 1.00
≤10 years 85 (14.0) 9 1.16 (0.52-2.31) 1.46 (0.54-3.56)
>10 years 64 (10.5) 2 0.35 (0.06-1.15) 0.33 (0.02-1.74)
Missing 16 2
Frequency of use (times per year
Never 443 (72.9) 35 1.00 1.00
≤6 83 (13.7) 5 0.75 (0.26-1.74) 0.62 (0.14-1.94)
>6 63 (10.4) 7 1.07 (0.43-2.28) 2.15 (0.70-6.03)
Missing 19 1
Regular exercise
No 252 (41.4) 34 1.00 1.00
Yes 353 (58.1) 14 0.27 (0.14-0.50)* 0.37 (0.16-0.83)*
Missing 3 0
Frequency of exercise (times per week)
Never 252 (41.4) 34 1.00 1.00
1-6 161 (26.5) 7 0.34 (0.14-0.73)* 0.66 (0.22-1.82)
≥7 188 (30.9) 6 0.20 (0.08-0.45)* 0.23 (0.07-0.65)*
Missing 7 1
Clinical stageb
Localized 290 (47.7) 7 1.00 1.00
Locally advanced 158 (26.0) 7 1.95 (0.67-5.71) 1.56 (0.41-5.69)
Bone metastasis 154 (25.3) 34 12.10 (5.64-29.99)* 10.15 (3.22-35.98*
Missing 6 0
Abbreviation: AHR adjusted HR, HR: hazard ratio
*P-value < 0.05; aAdjusting for clinical stage, PSA, age, marital status, blood type, education, family history of PC, cigarette smoking, alcohol drinking, and betel
nut chewing
bTumor, node, metastasis system staging by American Joint Committee on Cancer (1997): Localized, T1/T2 N0 M0; Locally advanced, T3/T4 N1 M0; Bone
Metastasis, M1
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This study found an association that persisted after
confounding adjustment, indicating that the use of hair
dye may increase the risk of prostate cancer, but was un-
related to the clinical stage and prostate-cancer-specific
death. The increased risk was observed in study patients
who started to use hair dye products before 1980. Dose–
response effects of increased exposure duration and
frequency were also observed.
Few observational studies have investigated the associ-
ation between hair dye use and prostate cancer risk, and
their findings have been inconsistent [21, 41]. Guberan
et al. examined 703 male and 677 female registeredhairdressers who began managing salons in Geneva,
Switzerland, between 1900 and 1964. The study partici-
pants were followed up until the end of 1982, and any
incident of cancer between 1970 and 1980 was recorded
[21]. The author observed an increased incident risk of
all neoplasms, including prostate cancer, among the men
(observed = 12 incident cases, expected = 6.1 incident
cases; P < .05). Because the personal information in
their study included only sex, age, marital status, and
occupation, the confounding bias caused by other life-
style factors was unavoidable. Another ecological study
on cancer mortality among professions that involve
making contact with hair dyes in the United States
Tai et al. BMC Cancer  (2016) 16:242 Page 10 of 12determined that no increased prostate cancer mortality
rates existed [41].
Hair dyes manufactured before the 1980s contained
carcinogenic agents such as aromatic amines and p-
phenylenediamine that can be absorbed through the skin
and are suspected to be among the main causes of
urothelial cancer in humans [42–45]. Thus, in 1979, the
U.S. Food and Drug Administration required a cancer
warning label to be placed on the packaging of various
hair dye products [46], and from 1978 to 1982, all oxida-
tive dye products were reformulated to eliminate ingre-
dients that were reportedly mutagenic or carcinogenic
[16, 46]. The year in which dye formulas were changed
is consistent with our results that a first use of hair dye
before 1980 increased the risk of prostate cancer.
Although the exact effect that the carcinogenic agents in
hair dyes exert on the prostate is unknown, the carcino-
gens could possibly be absorbed through the urothelial
epithelium and accumulate in the prostate gland, con-
tributing to the malignancy of the prostate.
Regular exercise significantly reduces prostate-cancer-
specific death, particularly in patients with bone metasta-
sis. By contrast, regular exercise may not protect against
developing prostate cancer, a result that was verified in
the sensitivity analysis. Although numerous epidemiologic
studies have examined the relationship between physical
activity and the risk of prostate cancer [26–28, 30, 47–55],
few of them have explored its effect on prostate-cancer-
specific mortality. Currently, approximately 40 human
studies have investigated physical activity and the risk of
prostate cancer; however, less than 40 % of these studies
(14 studies) have determined a significant protective effect.
Most recent human studies have focused on the
effect that regular exercise exerts on clinically ad-
vanced prostate cancer or prostate-cancer-specific
death [29, 48, 49, 53–55], and most of them have
suggested a protective effect with higher levels of rec-
reational physical activity [48, 49, 53, 54]. However,
they have observed no association between recre-
ational physical activity and overall prostate cancer
risk [48, 53].
The protective mechanism of physical activity on the
survival of prostate cancer patients is likely attributable
to the influence of various hormones, such as insulin
[56, 57] and androgens [57], and other growth factors
that are related to the aggressiveness of prostate cancer.
Physical activity provides another protective mechanism
that enhances immune function and antioxidant defense
mechanisms, resulting in the increase of the survival rate
of prostate cancer patients.
A limitation of this study was that the controls com-
prised volunteers who participated in health check-ups;
thus, this group might not have been representative of
the general population. Another limitation is that thiswas a multicenter hospital-based case–control study,
and the exposures of interest were determined using a
questionnaire; therefore, recall bias was likely. Although
we verified the accuracy of various questionnaire items,
such as cigarette smoking, alcohol consumption, and betel
nut chewing obtained from previous studies [32–34], the
bias was unavoidable. In addition, other unmeasured con-
founders might have been present. Another limitation is
that no detailed information regarding the various brands
of or ingredients in the hair dyes, which might have con-
tained various levels of carcinogenic chemicals, was in-
cluded. However, we asked “What year did you start using
hair dyes, before or after 1980?”. Although we did not ask
about the color of hair dyes, in Taiwan, most people use
black or dark hair dyes to dye their grey hair and appear
younger. Finally, we obtained no information on regular
exercise performed after diagnoses of prostate cancer.
Therefore, we were unable to clarify whether the protect-
ive effect of regular exercise on the survival of prostate
cancer patients was caused by the benefit of exercise
before or after the diagnosis, or whether the 2 were highly
correlated.
Conclusions
In conclusion, we determined that hair dye use was
associated with an increased prostate cancer risk; however,
hair dye use was unrelated to the survival of prostate can-
cer patients. By contrast, regular exercise reduced the risk
of prostate-cancer-specific death but did not protect
against the risk of prostate cancer.
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